By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Abbott today said that it has licensed exclusive rights from Stanford University to several biomarkers that it intends to use in developing a molecular diagnostics test.

Abbott said that it intends to develop a test that can differentiate aggressive from nonaggressive prostate cancer, a currently unmet medical need.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: new gene linked to ocular coloboma, new statistical model for interrogating gene expression networks, and more.

With a new collection, PLOS highlights negative results it has published.

A pair of researchers examines political leanings and views on genomics, finding more of a role for optimism and pessimism in people's views.

The genome of the carnivorous bladderwort is smaller than many other plant genomes, but it still holds on to important genes.